EP0723458A4 - Modulation immunitaire a l'aide de fragments de chaine alpha de classe ii - Google Patents

Modulation immunitaire a l'aide de fragments de chaine alpha de classe ii

Info

Publication number
EP0723458A4
EP0723458A4 EP95922332A EP95922332A EP0723458A4 EP 0723458 A4 EP0723458 A4 EP 0723458A4 EP 95922332 A EP95922332 A EP 95922332A EP 95922332 A EP95922332 A EP 95922332A EP 0723458 A4 EP0723458 A4 EP 0723458A4
Authority
EP
European Patent Office
Prior art keywords
alpha
class
chain fragments
immune modulation
immune
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP95922332A
Other languages
German (de)
English (en)
Other versions
EP0723458A1 (fr
Inventor
Carol Clayberger
Alan M Krensky
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Leland Stanford Junior University
Original Assignee
Leland Stanford Junior University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leland Stanford Junior University filed Critical Leland Stanford Junior University
Publication of EP0723458A1 publication Critical patent/EP0723458A1/fr
Publication of EP0723458A4 publication Critical patent/EP0723458A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70539—MHC-molecules, e.g. HLA-molecules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4738—Cell cycle regulated proteins, e.g. cyclin, CDC, INK-CCR
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EP95922332A 1994-06-16 1995-06-16 Modulation immunitaire a l'aide de fragments de chaine alpha de classe ii Withdrawn EP0723458A4 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US26054894A 1994-06-16 1994-06-16
PCT/US1995/007673 WO1995034321A1 (fr) 1994-06-16 1995-06-16 Modulation immunitaire a l'aide de fragments de chaine alpha de classe ii
US260548 2005-10-27

Publications (2)

Publication Number Publication Date
EP0723458A1 EP0723458A1 (fr) 1996-07-31
EP0723458A4 true EP0723458A4 (fr) 1998-03-11

Family

ID=22989611

Family Applications (1)

Application Number Title Priority Date Filing Date
EP95922332A Withdrawn EP0723458A4 (fr) 1994-06-16 1995-06-16 Modulation immunitaire a l'aide de fragments de chaine alpha de classe ii

Country Status (5)

Country Link
EP (1) EP0723458A4 (fr)
JP (1) JPH09503003A (fr)
AU (1) AU2705795A (fr)
CA (1) CA2169762A1 (fr)
WO (1) WO1995034321A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6436903B1 (en) * 1996-05-22 2002-08-20 Stanford University (Board Of Trustees Of The Leland Standford Junior University) Immunomodulating compounds comprising d-isomers of amino acids
AU7298398A (en) * 1996-11-19 1998-06-10 Sangstat Medical Corporation Enhanced effects for hapten conjugated therapeutics
AU4454700A (en) * 1999-04-12 2000-11-14 Stanford University Interaction of mhc class ii proteins with members of the pcna family of proteins
KR100863632B1 (ko) 2000-03-31 2008-10-15 퍼듀 리서치 파운데이션 리간드-면역원 접합체를 사용한 치료 방법
GB0609121D0 (en) 2006-05-09 2006-06-21 Univ Birmingham Peptide Therapy

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991014701A1 (fr) * 1990-03-21 1991-10-03 The Board Of Trustees Of The Leland Stanford Junior University Molecules ameliorees de complexe majeur d'histocompatibilite (cmh)
WO1994013320A1 (fr) * 1992-12-17 1994-06-23 Subramaniam Sriram Vaccination a l'aide d'un peptide de molecules de classe ii du complexe majeur d'histocompatibilite (mhc) pour le au traitement de maladies autoimmunes

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0006916B1 (fr) * 1977-09-28 1981-07-08 National Research Development Corporation Préparations immunoligiques contenant MHC antigens et leur production
US5130295A (en) * 1989-01-05 1992-07-14 Consortium For Surface Processing Passivating thin film for superconducting material

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991014701A1 (fr) * 1990-03-21 1991-10-03 The Board Of Trustees Of The Leland Stanford Junior University Molecules ameliorees de complexe majeur d'histocompatibilite (cmh)
WO1994013320A1 (fr) * 1992-12-17 1994-06-23 Subramaniam Sriram Vaccination a l'aide d'un peptide de molecules de classe ii du complexe majeur d'histocompatibilite (mhc) pour le au traitement de maladies autoimmunes

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
B. AGRAWAL ET AL.: "T cells that recognize peptide sequences of self MHC class II molecules exist in syngeneic mice.", THE JOURNAL OF IMMUNOLOGY, vol. 147, no. 2, 15 July 1991 (1991-07-15), BALTIMORE, MD, USA, pages 383 - 390, XP002050664 *
B. COHEN ET AL.: "Cytotoxic T cell recognition of an endogenous class I HLA peptide presented by a class II HLA molecule.", THE JOURNAL OF EXPERIMENTAL MEDICINE, vol. 172, no. 3, 1 September 1990 (1990-09-01), NEW YORK, NY, USA, pages 779 - 788, XP002050665 *
See also references of WO9534321A1 *

Also Published As

Publication number Publication date
AU2705795A (en) 1996-01-05
WO1995034321A1 (fr) 1995-12-21
CA2169762A1 (fr) 1995-12-21
EP0723458A1 (fr) 1996-07-31
JPH09503003A (ja) 1997-03-25

Similar Documents

Publication Publication Date Title
GB2294770B (en) Induction logging
ZA959336B (en) Antibodies
ZA958634B (en) Cookware
GB2289284B (en) Alkylpolysiloxanes
SG83154A1 (en) Heat-resistant adhesive
EP0723458A4 (fr) Modulation immunitaire a l'aide de fragments de chaine alpha de classe ii
GB9402448D0 (en) Luminaires
GB2292212B (en) Luminaires
GB9724006D0 (en) Laminated glass
KR0112312Y1 (en) Pulleys
GB9404185D0 (en) Picnic glass
GB9402593D0 (en) Antibody fragments
GB2315540B (en) Heat excahnger
CA74225S (en) Glass shade
GB9314899D0 (en) Tumour-associated antigen
GB9408137D0 (en) Dimmer
GB9516700D0 (en) Browning device
HU9801016D0 (en) Polipeptide promoting thrombocytopoesis
GB9414132D0 (en) Put n two
GB9403731D0 (en) Bulb mate
GB9416932D0 (en) Tumour specific photeoglycan
GB9424481D0 (en) Drive stop
GB9414520D0 (en) Sealed drive
PL302547A1 (en) Drive
GB9424623D0 (en) Drive aasemblies

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19960301

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

A4 Supplementary search report drawn up and despatched

Effective date: 19980123

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

17Q First examination report despatched

Effective date: 20000321

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20020102